News

The valuation boom (or bust)

With valuations at an all-time high and investment risk on the rise, some VCs are wisely showing caution

Venture-backed stocks gain in February

Index of venture-backed stocks rises nearly 50 points to end at its highest mark since last fall

Life sciences still dominate new issues, though they see below-range pricing

Through the first two months of the year, 12 VC-backed stocks have debuted on the NYSE or Nasdaq

The next round is on Homebrew

Upstart San Francisco firm raises $85 million in capital for second seed fund and new growth vehicle

Insurer AXA to embrace startups with venture fund launch

AXA Strategic Ventures will invest in tech companies related to insurance, healthcare, asset management and fintech

IPO Profile: Nexvet Biopharma PLC

The Australia-based biopharma company went public on the Nasdaq in a $40 million offering

Fund briefs

A recap of recent venture fundraising news worldwide; plus tables on firms that have held closings

Canadian innovation network nabs $15.5 mln to drive genomics research

Genome Canada has made a $15.5 million investment in the Genomics Innovation Network, a network of Canadian innovation centres that is intended to advance research in genomics, metabolomics, proteomics and related areas. The network is comprised of ten "nodes", each of which will receive operational funding from Genome Canada and matching funds from public and private sector partners. Genome Canada is a federally-funded non-profit organization focused on the development of genomics and genomic-based technologies.

The growing role of the fund administrator

Augentius’ David Bailey talks about the greater LP interest in fund administrators and why firms are looking more closely

Crowdfunding growth accelerated last year with $16.2 bln raised

Crowdfunding continues to grow rapidly worldwide, with $16.2 billion raised for companies, causes and individuals in 2014, according to a study by Massolution.